A Public-Source Oncology Research Platform
Structured, Source-Linked Research Context
CS Cancer Solutions is an operating research platform that organizes public oncology research, trial-registry information, biomarkers, and institutional context for educational and research exploration — so visitors can explore cancer research evidence in one structured place rather than across many separate public sources.
See the Platform Working Today
These resources are available on the platform now. Each is described exactly as a visitor will find it.
Ocular (Uveal) Melanoma Evidence Module
A dated evidence summary presenting research context for this uncommon cancer type: historical treatment landscape, checkpoint-inhibitor findings, tebentafusp evidence, ongoing research, and how to interpret trial outcomes — with listed public sources and medical disclaimers.
View the Ocular Melanoma ModuleClinical-Trial Records from Public Registries
Trial records drawn from public registries such as ClinicalTrials.gov, browsable by region, with links to the original registry record. Coverage is partial, some records are incomplete, and listings are research information — not trial matching or eligibility assessment.
Browse Clinical-Trial RecordsWe are not a generic medical website.
We are an operating public-source oncology research platform.
Here is what that means in practice.
8 Ways We're Different
Public evidence, organized for exploration
Public oncology information is spread across trial registries, literature databases, and institutional websites. CS Cancer Solutions brings selected public research context — cancer types, clinical-trial records, biomarkers, and institutional listings — into one structured, browsable platform.
Cancer types, trials, biomarkers, institutions
Records are grouped by cancer type, clinical trial, biomarker, and institution, so a visitor can move between related research context instead of reconstructing it across separate sites. Coverage varies across areas and continues to expand.
Country and U.S. state research context
Country-specific research profiles and U.S. state research-ecosystem pages let visitors explore oncology research context geographically, alongside international clinical-trial records drawn from public registries.
Check the source, not just the summary
Where available, records link to the original public source so visitors can verify what they read. Links are provided where available; coverage of sources and links varies, and no fixed refresh schedule is guaranteed.
Starting with ocular melanoma
Uncommon cancers often have fragmented, hard-to-find evidence. The ocular (uveal) melanoma module presents the research context for this cancer type — treatment history, research directions, and how to interpret trial outcomes. It is currently the platform's only live rare-cancer module; similar modules for other cancer types are in development.
No purchasable membership required
The platform's research and educational resources are free to browse. No premium tiers or paid memberships are sold. A scoped institutional research pilot can be discussed, and annual research-program models are under exploration.
Browser-based, not professionally reviewed
Page content can be machine-translated through the site's translation tool and standard browser translation. Translations are machine-generated, may be imperfect, and are not professionally reviewed.
Informational, not medical guidance
The platform is not intended to receive or process patient information. Do not submit personal medical information. Specialist and treatment-center listings are informational only — not referrals, rankings, or recommendations. Content is educational and research context, not medical advice.
CS Cancer Solutions organizes that public evidence for exploration — the original sources remain the authority.
Our Commitments to You
Public sources, linked where available
Educational and research use only
No patient information requested
Free public access to resources
Not medical advice, not referrals or rankings
No fixed refresh schedule is guaranteed
Built From Personal Research Experience
Founder Suvi M. Bayly began this work while supporting her father through his ocular melanoma diagnosis and the fragmented search for research information that followed.
Read the Founder StoryExplore the Public Research Resources
Whether you're a researcher, a member of an institutional team, or exploring cancer research for the first time — the platform's public resources are free to browse.
A scoped institutional research pilot can be discussed, and annual research-program models are under exploration.